selegiline hydrochloride

Generic: selegiline hydrochloride

Labeler: a2a integrated pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name selegiline hydrochloride
Generic Name selegiline hydrochloride
Labeler a2a integrated pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

selegiline hydrochloride 5 mg/1

Manufacturer
A2A Integrated Pharmaceuticals

Identifiers & Regulatory

Product NDC 73141-006
Product ID 73141-006_339f9a9e-dffc-daac-e063-6294a90ae1fe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074672
Listing Expiration 2026-12-31
Marketing Start 2024-03-15

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa] monoamine oxidase type b inhibitor [epc] monoamine oxidase-b inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73141006
Hyphenated Format 73141-006

Supplemental Identifiers

RxCUI
859193
UPC
0373141006027
UNII
6W731X367Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name selegiline hydrochloride (source: ndc)
Generic Name selegiline hydrochloride (source: ndc)
Application Number ANDA074672 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (73141-006-02)
source: ndc

Packages (1)

73141-006-02 60 TABLET in 1 BOTTLE (73141-006-02)

Ingredients (1)

selegiline hydrochloride (5 mg/1)

Linked Drug Pages (1)

Selegiline Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "339f9a9e-dffc-daac-e063-6294a90ae1fe", "openfda": {"upc": ["0373141006027"], "unii": ["6W731X367Q"], "rxcui": ["859193"], "spl_set_id": ["a59ff47b-4379-44f3-9d2c-f8c6121d1881"], "manufacturer_name": ["A2A Integrated Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (73141-006-02)", "package_ndc": "73141-006-02", "marketing_start_date": "20240315"}], "brand_name": "Selegiline Hydrochloride", "product_id": "73141-006_339f9a9e-dffc-daac-e063-6294a90ae1fe", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]", "Monoamine Oxidase Type B Inhibitor [EPC]", "Monoamine Oxidase-B Inhibitors [MoA]"], "product_ndc": "73141-006", "generic_name": "Selegiline Hydrochloride", "labeler_name": "A2A Integrated Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Selegiline Hydrochloride", "active_ingredients": [{"name": "SELEGILINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA074672", "marketing_category": "ANDA", "marketing_start_date": "20240315", "listing_expiration_date": "20261231"}